AposHealth Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • AposHealth's estimated annual revenue is currently $14.6M per year.(i)
  • AposHealth's estimated revenue per employee is $140,000

Employee Data

  • AposHealth has 104 Employees.(i)
  • AposHealth grew their employee count by 42% last year.

AposHealth's People

NameTitleEmail/Phone
1
SVP, Chief Operations OfficerReveal Email/Phone
2
SVP, Chief Marketing OfficerReveal Email/Phone
3
Chief Compliance OfficerReveal Email/Phone
4
Chief Marketing OfficerReveal Email/Phone
5
EVP, Chief Medical OfficerReveal Email/Phone
6
VP, Chief Financial OfficerReveal Email/Phone
7
SVP, Chief Technology OfficerReveal Email/Phone
8
EVP, Chief Scientific and Innovation OfficerReveal Email/Phone
9
SVP, Business Development OfficerReveal Email/Phone
10
VP AnalyticsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1M740%N/AN/A
#2
$14.6M10442%N/AN/A
Add Company

What Is AposHealth?

We at AposHealth® are passionate about revolutionizing the musculoskeletal category by simply addressing people’s gait (how they move) to help alleviate pain, move better, and live better.\n\nOur flagship solution, Apos®, is doing just that. Apos® is FDA-cleared for treating knee osteoarthritis to temporarily reduce knee pain. It can also be used as a general wellness device to help patients live well with chronic lower back and hip pain. \n\nWith a 96% satisfaction rate and over 100,000 patients treated, this treatment, consisting of gait analysis, a personalized foot-worn medical device, and a customized treatment plan, has helped our members with chronic knee, lower back, and hip pain worldwide move, live, and thrive.

keywords:N/A

N/A

Total Funding

104

Number of Employees

$14.6M

Revenue (est)

42%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$25.3M10422%N/A
#2
$25.3M104-2%N/A
#3
$26.4M1044%N/A
#4
$33.8M1042%N/A
#5
$15.1M104N/AN/A